CHICAGO (PRWEB) March 24, 2023 -- CancerIQ will showcase its latest precision cancer prevention and early detection offerings for breast centers at the 32nd Annual Interdisciplinary Breast Center Conference (NCoBC 2023) in Las Vegas, March 24-28, (Booth #301). The company will offer NCoBC attendees an exclusive first look at two exciting new offerings: CancerIQ Complete, the industry’s first full-service suite designed to help breast centers start, run and grow high-risk breast programs; and a new real-time, EHR-initiated CancerIQ Risk Calculator.
CancerIQ is a digital healthcare technology platform that helps health systems and breast centers move beyond the traditional, one-size-fits all approach to cancer risk assessment and screening. Too often this approach allows high-risk patients to fall through the cracks, leading to later-stage cancer diagnoses and more costly care. CancerIQ helps providers traverse the challenges of managing population-wide cancer risk assessment to offer more personalized, evidence-based care pathways that lead to early cancer detection and prevention.
The new CancerIQ offerings unveiled at NCoBC will help busy breast centers at any stage of the precision prevention journey grow their impact and help more patients get ahead of cancer. Visit Booth #301 to learn how:
- CancerIQ Complete helps instantly scale high-risk breast programs with virtual services. Breast centers can now build robust high-risk programs, even with limited staff and resources. CancerIQ Complete is a full-service virtual navigation and genetic counseling program, designed to fill staffing gaps, increase patient access to pre- and post-test genetic counseling services, and ensure patients are navigated to the appropriate care within the health system. These services ensure breast centers have the resources they need to complete the crucial connection between risk assessment and preventive care pathways, including breast MRIs, prophylactic surgeries and chemoprevention.
- The new Risk Score Calculator brings comprehensive risk assessment into leading EHR workflows. With this HL7 integration, customers can natively capture patient risk factors within EHR software, send structured data to CancerIQ’s up-to-date risk calculator, and seamlessly populate existing workflows with Tyrer-Cuzick scores (7 and 8), as well as NCCN guidelines. The update enables breast center staff to offer patients the most comprehensive risk assessment available to date, while maintaining workflow efficiency — an important first step in the journey to precision cancer prevention and early detection. It also eliminates the need to update IT builds as guidelines and risk models evolve, ensuring every patient receives high-quality care and centers continue to meet accreditation standards.
“Our mission at CancerIQ is to help patients stay ahead of cancer with precision prevention and early detection. But we recognize that offering personalized cancer prevention pathways at the population level can be a major challenge in today’s healthcare environment. That’s why CancerIQ is launching a service to provide remote staffing services. We want to ensure health systems can bridge genetic counseling and patient navigation resource gaps, so they can more equitably offer access to services patients need to stay ahead of cancer,” said Feyi Ayodele, co-founder and CEO of CancerIQ.
-
Learn More at NCoBC
CancerIQ is proudly sponsoring the High Risk IT Forum in the Pre-Conference High Risk Breast Program: Essentials for Success. Visit us at Booth #301 or book a time to connect by emailing [email protected]
Can’t make it to Las Vegas? Learn more about how a modern approach to cancer risk assessment can drive better clinical and financial outcomes with “The Definitive Guide to High-Risk Breast Programs.” Download the free e-book here.
-
About CancerIQ
CancerIQ is the only cancer-focused precision health platform that empowers healthcare providers to detect cancer earlier and prevent it altogether across all patient populations. Integrated directly into real-time EHR workflows, CancerIQ makes it easy to gather comprehensive patient data, automatically map it to the latest evidence-based guidelines, and expand access to personalized care plans, cutting-edge clinical solutions, and genomic innovations. Learn more at canceriq.com, follow CancerIQ on Twitter, LinkedIn or Facebook.
Malvina Kefalas, CancerIQ, http://www.canceriq.com, 1 5165038610, [email protected]
Share this article